Issue |
Section |
Title |
File |
Vol 82, No 12 (2010) |
Editorial |
Pharmacogenetic criteria for the efficacy of basic anti-inflammatory therapy for rheumatoid arthritis |
|
Vol 84, No 10 (2012) |
Editorial |
Cytokine gene polymorphism in type 2 diabetes mellitus in the Europeoid women of Russia |
|
Vol 85, No 5 (2013) |
Editorial |
Genetic factors of angiogenic dysregulation in women with rheumatoid arthritis |
|
Vol 86, No 4 (2014) |
Editorial |
Analysis of genotypes combinations at the polymorphic points of the promoter regions of the genes of three matrix metalloproteinases and the gene of vascular endothelial growth factor (VEGF) in patients with prior acute myocardial infarction |
|
Vol 87, No 6 (2015) |
Editorial |
Increased serum concentrations of inflammatory cytokines in type 2 diabetic patients with chronic kidney disease |
|
Vol 87, No 12 (2015) |
Editorial |
Matrix metalloproteinase 2, 3, and 9 gene polymorphisms in women with rheumatoid arthritis |
|
Vol 89, No 5 (2017) |
Editorial |
Polymorphism in the regulatory regions –С2578A and +C936T of the vascular endothelial growth factor (VEGF-A) gene in Russian women with rheumatoid arthritis |
 (Rus)
|
Vol 88, No 10 (2016) |
Editorial |
Acute-phase serum proteins and adipocytokines in women with type 2 diabetes mellitus: Relationships with body composition and blood glucose fluctuations |
 (Rus)
|
Vol 82, No 1 (2010) |
Editorial |
Analysis of the gene polymorphism of matrix metalloproteinase-2 and -9 in patients with coronary heart disease |
|
Vol 91, No 10 (2019) |
Editorial |
Ghrelin deficiency in patients with type 2 diabetes: the relationships with obesity, adipose tissue dysfunction and glucose variability |
 (Rus)
|